Rare diseases
Investigational molecules
Locations
Back to Belgium21 clinical trials in Verviers, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
BelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumThe busiest research cities in the country
What the registry says about research in the country
Several groundbreaking trials focusing on hormone receptor-positive breast cancer treatment, particularly examining new therapeutic approaches for patients with HER2-negative variants.
Studies aim to enhance survival rates and reduce recurrence risks through targeted treatments.
Comprehensive research into various types of B-cell and T-cell lymphomas, including innovative treatments for both aggressive and indolent forms.
Investigations focus on comparing new treatment approaches against standard therapies.
Advanced studies examining treatments for relapsed/refractory multiple myeloma, testing innovative therapeutic approaches.
Research aims to improve outcomes for patients who have received prior therapies.
Innovative trials in colorectal cancer treatment, particularly focusing on patients with specific genetic mutations.
Studies evaluate both targeted therapies and standard treatment combinations.
Research focusing on advanced and recurrent endometrial cancer, exploring maintenance therapy options.
Trials aim to improve long-term outcomes following conventional treatment.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
